Harm Sinnige

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +16

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Miriam Koopman, Ninja Antonini, Joep Douma et al. · The Lancet · 2007 · 631 citations

Medicine, Oncology, Pharmacology +12

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman et al. · Blood · 2009 · 275 citations · Full text

Medicine, Hematology, Oncology +17

Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study

Pierre W. Wijermans, M. Ronald Schaafsma, Fabian Termorshuizen et al. · Journal of Clinical Oncology · 2010 · 262 citations

Medicine, Oncology, Pharmacotherapy +17

Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients

Gerwin Huls, Dana Chiţu, Violaine Havelange et al. · Blood · 2019 · 176 citations · Full text

Medicine, Oncology, Pharmacology +3